Adrenal and pituitary effects of mitotane in Cushing's syndrome.
作者信息
Kasperlik-Załuska A, Jeske W, Migdalska B
出版信息
Endokrynol Pol. 1986;37(1):17-21.
PMID:3015579
Abstract
摘要
相似文献
1
Adrenal and pituitary effects of mitotane in Cushing's syndrome.米托坦在库欣综合征中的肾上腺和垂体效应。
Endokrynol Pol. 1986;37(1):17-21.
2
3
[The medical management of Cushing's syndrome].[库欣综合征的药物治疗]
Endocrinol Nutr. 2009 Apr;56(4):187-94. doi: 10.1016/S1575-0922(09)70983-0. Epub 2009 Jun 11.
4
[Therapy of Cushing's syndrome].
Dtsch Med Wochenschr. 1985 Dec 6;110(49):1900-2. doi: 10.1055/s-2008-1069111.
5
[Studies on drug therapy of Cushing's syndrome].[库欣综合征的药物治疗研究]
Verh Dtsch Ges Inn Med. 1977;83:1337-40.
6
[The medical treatment of Cushing's syndrome: conclusions drawn from 220 cases].[库欣综合征的医学治疗：来自220例病例的结论]
Bull Mem Acad R Med Belg. 1978;133(2 Pt 2):181-92.
7
Current therapeutic concepts--Cushing's syndrome.
J Am Pharm Assoc. 1975 May;15(5):261-70.
8
[Neurotoxicity of mitotane therapy of adrenocortical carcinoma (5 cases) and Cushing's syndrome (7 cases)].米托坦治疗肾上腺皮质癌（5例）和库欣综合征（7例）的神经毒性
Presse Med. 1987 May 23;16(19):951-4.
9
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma.对于晚期肾上腺皮质癌所致库欣综合征，在化疗加米托坦的基础上加用美替拉酮。
Endocrine. 2018 Jul;61(1):169-172. doi: 10.1007/s12020-017-1428-9. Epub 2017 Oct 10.
10
Effect of o,p'-DDD on plasma ACTH concentration in Cushing's disease.
Medicina (B Aires). 1979 Mar-Apr;39(2):229-34.
Zotero 插件